A patient inquiry about ocular changes may provide pharmacists with an opportunity to screen or refer patients to an optometrist.

Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

Over-reliance on urine dipstick testing to guide urinary tract infection management contributes to antibiotic overuse and misuse.

A popular wonder drug of the 19th century, this patent medicine packed multiple punches. In 1848, Dr John Collis Browne had a problem. After training as a doctor in London and building his professional expertise, he had joined the Army...

Sarsparilla comes in teas, tablets, tinctures, and capsules. While use is widespread, evidence of its medical effectiveness is limited.

This summary will present the most up to date findings from a recent Cochrane review.1 Background It is estimated that a total of 2.8 million people are affected by multiple sclerosis (MS) worldwide. The pooled incidence rate is 2.1 per 100,000...

It comes in teas, tablets, tinctures, and capsules, and may only look good. In colonial Australia sarsaparilla was a hit. Like their American counterparts the British arrivals borrowed from the indigenous people, using the root of the vine as a...

How pharmacists can improve the lives of people living with disabilities through careful medicine reviews and follow-up. Just like medicine safety challenges in aged care, disability care is rife with safety problems with medicines – not the least of which...

Pharmacists have the skills and capacity to support people with intellectual and developmental disabilities (IDD), but often don’t know where to start. Speak to the person, not their carer Health professionals, including pharmacists, cite communication problems as a barrier. These are...

A review of aged care patients’ medicines can reduce harm. Welcome change is coming for government-funded residential aged care facilities (RACFs) with the investment in on-site pharmacists and pharmacy services from 1 January 2023.1 But what will pharmacists in these...